Clinical trial
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth
NCT00106964 · University of North Carolina, Chapel Hill, Other · Completed
Key facts
| NCT number | NCT00106964 |
|---|---|
| Title | Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth |
| Official title | A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH National Institute of Mental Health (NIMH) National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection, Hepatitis B |
| Intervention type | Biological |
| Interventions | Engerix-B 20 mcg, Engerix-B 40 mcg, Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg |
| Enrollment | 371 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Apr 4, 2005 |
| Last update posted | Mar 29, 2017 |
| Countries | Brazil, South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: